PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1358036
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1358036
Custom Recombinant Protein Production Services Market, By Expression System, By End User, By Region
The global custom recombinant protein production services market is estimated to be valued at US$ 4.9 billion in 2023 and is expected to exhibit a CAGR of 11.5% during the forecast period (2023-2030).
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 4.9 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 11.50% | 2030 Value Projection: | US$ 10.5 Bn |
Recombinant proteins have a wide range of applications in biotechnology, research, and medicine. Custom recombinant protein production is one of the efficient techniques used in the life sciences sector that plays a major role in advanced healthcare. Recombinant proteins are developed by manipulating proteins using certain techniques. Genes are then used to encode these recombinant proteins, which are then produced in large quantities and used to make therapeutic and commercial products. Increasing government initiatives and funding in the field of life sciences is expected to boost growth of the market.
Many recombinant proteins require and provide post-translational modifications such as glycosylation, which are only available in eukaryotic, yeast, mammalian, and insect cell culture systems. HEK293-derived cell lines are used for transient protein production. Currently, most recombinant therapeutic proteins are produced in mammalian cells due to their ability to produce high-quality proteins similar in nature. In addition, many approved recombinant therapeutic proteins have been produced in E. coli due to well-characterized genetics, rapid growth, and high-yield production.
Market Dynamics
The increasing adoption of inorganic growth strategies such as acquisitions by the key players is expected to drive segment growth over the forecast period. For instance, in July 2021, Atlas Antibodies, a manufacturer of highly validated primary antibodies, acquired Evitria, a developer of transient recombinant antibody expression in Chinese hamster ovary (CHO) cells. CHO cells are the preferred expression system for recombinant therapeutic protein (RTP) production. The acquisition will combine the antibody solutions of both companies and expand their businesses.
Key features of the study:
- This report provides an in-depth analysis of the global custom recombinant protein production services market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global custom recombinant protein production services market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include GenScript Biotech Corporation, SignalChem Biotech Inc., Crown Bioscience, Inc., BPS Bioscience Inc., Novoprotein, Applied Biological Materials (abm) Inc., Eurofins Pharma Discovery Services, Abgent (WuXi AppTec Company), OriGene Technologies, Inc., Kempbio, Inc., Trenzyme GmbH, Sino Biological Inc., Aragen Bioscience, a GVKBIO Company, LakePharma, Inc., , Proteos Inc., Icosagen AS, Novus Biological LLC, Proteogenix, Premas Biotech, ATUM, and Aldevron
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global custom recombinant protein production services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global custom recombinant protein production services market.
Custom Recombinant Protein Production Services Market Detailed Segmentation:
- By Expression System:
- Mammalian
- Bacteria
- Insect
- Yeast
- Others
- By End User :
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
- Others
- By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- GenScript Biotech Corporation
- SignalChem Biotech Inc.
- Crown Bioscience, Inc.
- BPS Bioscience Inc.
- Novoprotein
- Applied Biological Materials (abm) Inc.
- Eurofins Pharma Discovery Services
- Abgent (WuXi AppTec Company)
- OriGene Technologies, Inc.
- Kempbio, Inc.
- Trenzyme GmbH
- Sino Biological Inc.
- Aragen Bioscience, a GVKBIO Company
- LakePharma, Inc.,
- Proteos Inc.
- Icosagen AS
- Novus Biological LLC
- Proteogenix
- Premas Biotech
- ATUM
- Aldevron
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Expression System
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Custom Recombinant Protein Production Services Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Custom Recombinant Protein Production Services Market, By Expression System , 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Bacteria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Insect
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Yeast
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
6. Global Custom Recombinant Protein Production Services Market, By End User, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
7. Global Custom Recombinant Protein Production Services Market, By Region, 2018 - 2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- GenScript Biotech Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- SignalChem Biotech Inc.
- Crown Bioscience, Inc.
- BPS Bioscience Inc.
- Novoprotein
- Applied Biological Materials (abm) Inc.
- Eurofins Pharma Discovery Services
- Abgent (WuXi AppTec Company)
- Kempbio, Inc.
- Trenzyme GmbH
- Sino Biological Inc.
- Aragen Bioscience, a GVKBIO Company
- LakePharma, Inc.
- Proteos Inc.
- Icosagen AS
- Novus Biological LLC
- Proteogenix
- Premas Biotech
- ATUM
- Aldevron
9. Section
- References
- Research Methodology
- About us and Contact
